Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (62)
  • 2024 (54)
  • 2023 (99)
  • 2022 (139)
  • 2021 (113)
  • 2020 (26)
  • 2019 (2)
  • 2018 (1)
  • 2017 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Major Law Enforcement Operation (267)
  • Diversion Division (242)
  • Intelligence Division - Intelligence Products (5)

Drug Name

  • Fentanyl (146)
  • Cocaine (113)
  • Methamphetamine (88)
  • Heroin (77)
  • Opioids (53)
  • Oxycodone (39)
  • Synthetic Opioids (26)
  • Marijuana (Cannabis) (22)
  • Hydromorphone (13)
  • Benzodiazepines (7)
  • Morphine (7)
  • Amphetamines (3)
  • Ecstasy/MDMA (3)
  • Methadone (3)
  • Steroids (3)
  • Marijuana Concentrates (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • K2/Spice (1)
  • Ketamine (1)
  • LSD (1)
  • Psilocybin (1)
  • Xylazine (1)

Field Division

  • Washington, DC (150)
  • New York (40)
  • New England (37)
  • Seattle (29)
  • El Paso (27)
  • New Jersey (23)
  • St. Louis (23)
  • Chicago (22)
  • Houston (21)
  • Sede (18)
  • San Francisco (16)
  • Atlanta (15)
  • Miami (15)
  • New Orleans (11)
  • Dallas (10)
  • San Diego (10)
  • Rocky Mountain (9)
  • Los Angeles (6)
  • Phoenix (6)
  • Omaha (4)
  • Louisville (3)
  • Detroit (1)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

Diciembre 04, 2025
Washington, DC – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment...
Diciembre 04, 2025
PRESS RELEASE

Former Ellensburg Doctor Indicted on 26 Felony Counts for Falsifying and Issuing Commercial Driver’s Licenses and Prescriptions for Controlled Substances

Diciembre 01, 2025
YAKIMA, Wash. – On November 14, 2025, a federal grand jury for the Eastern District of Washington returned an Indictment charging Anna Elperin, age 42, with 26 felony counts relating to prescriptions for controlled substances and Department of Transportation commercial driver’s licenses physical examinations Elperin wrote and performed at her...
Diciembre 01, 2025
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 20, 2025
SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
Noviembre 20, 2025
PRESS RELEASE

Pensacola Women Plead Guilty to Illegal Drug Diversion

Noviembre 17, 2025
PENSACOLA, FLA – Alexandra M. Christensen, 31, Lindsay N. McCray (also known as Lindsay Rogers), 42, Heather T. Bradley (also known as Heather Thomas), 37, and Jennifer E. Purves, 39, all of Pensacola, Fla., pleaded guilty in federal court to charges in connection with the unlawful diversion of controlled substances...
Noviembre 17, 2025
PRESS RELEASE

Communities Nationwide Join DEA and its Partners to Safely Dispose of 571,000 pounds of Unwanted Medications

Noviembre 03, 2025
SAN FRANCISCO – On October 25, 2025, DEA joined 4,263 law enforcement agencies across the country who came together for the 29th National Prescription Drug Take Back Day. At 4,317 collection sites nationwide, Take Back events removed 571,054 pounds of unneeded and expired medications from home medicine cabinets to prevent...
Noviembre 03, 2025
PRESS RELEASE

DEA New Orleans Division Delivers Major Blow to CJNG; Arkansas Leads Division with 25 Arrests in Four-State Sweep

Septiembre 29, 2025
NEW ORLEANS – Today, the Drug Enforcement Administration announced the results of a week-long operational surge aimed at dismantling the Jalisco New Generation Cartel (CJNG), one of the most violent and prolific drug trafficking organizations in the world. Designated as a Foreign Terrorist Organization in February by the Trump Administration...
Septiembre 29, 2025
PRESS RELEASE

Operation Vape Trail Cracks Down on Illegal Substances in Vape Shops

Septiembre 25, 2025
WASHINGTON, DC – The Drug Enforcement Administration announced the results of a week-long operational enforcement action as part of a whole-of-government initiative aimed at removing dangerous and illegal vaping substances from communities across America. During the operation, DEA seized more than 2.3 million vape devices and cartridges and more than...
Septiembre 25, 2025
PRESS RELEASE

Owner of Kansas City, Kansas Pharmacy Agrees to Pay $200,000 to Resolve Allegations of Violating the Controlled Substances Act

Septiembre 24, 2025
KANSAS CITY, KAN. – Daniel Reif, Inc., doing business as The Medicine Shoppe, a retail pharmacy in Kansas City, Kansas, entered into a civil settlement agreement with the federal government agreeing to pay $200,000 to resolve allegations the pharmacy violated the civil provisions of the Controlled Substances Act (CSA). The...
Septiembre 24, 2025
PRESS RELEASE

Operation Vape Trail Cracks Down on Illegal Substances in Vape Shops

Septiembre 22, 2025
WASHINGTON – Today, the Drug Enforcement Administration announced the results of a week-long operational enforcement action as part of a whole-of-government initiative aimed at removing dangerous and illegal vaping substances from communities across America. During the operation, DEA seized more than 2.3 million vape devices and cartridges and more than...
Septiembre 22, 2025
PRESS RELEASE

DEA Surge Targets Sinaloa Cartel Networks Worldwide

Septiembre 09, 2025
San Francisco – September 9, 2025, the Drug Enforcement Administration announced the results of a week-long operational surge aimed at dismantling the Sinaloa Cartel, one of the world’s most violent and powerful drug cartels, responsible for flooding the United States with fentanyl, methamphetamine, cocaine, and heroin. In February, the Trump...
Septiembre 09, 2025
Showing 1 - 10 of 497 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Página 9
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster